OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form

Jeffrey Fudin, Mena Raouf, Erica Wegrzyn
  • Journal of Pain Research, September 2016, Dove Medical Press
  • DOI: 10.2147/jpr.s117219

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication


The following have contributed to this page: Dr Jeffrey Fudin and Dr. Erica L. Wegrzyn